Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

Annals of Neurology

Volumn 44, Issue 2, 1998, Pages 177-186

  Gu, M ^a   Cooper, J M ^a   Taanman, J W ^a   Schapira, A H V ^a,b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA TRANSFER; GENE MUTATION; HUMAN; HUMAN CELL; MITOCHONDRION; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0031859395     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440207     Document Type: Article

References (42)

1. Román GC, Zhang Z-X, Ellenberg JH. The neuroepidemiology of Parkinson's disease. In: Ellenberg JH, Koller WC, Langston JW, eds. Etiology of Parkinson's disease. New York: Marcel Dekker, 1995:203-343
2. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047
3. Dexter DT, Carter CJ, Wells FR, et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989;52:381-389
4. Sanchez-Ramos J, Övervik E, Ames BN. A marker of oxyradical-mediated DNA damage (8-hydroxy-2′deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration 1994;3:197-204
5. Olanow CW. A radical hypothesis for neurodegeneration. Trends Neurosci 1993;16:439-444
6. Riederer P, Sofic E, Rausch WD, et al. Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains. J Neurochem 1989;52:515-520
7. Dexter DT, Wells FR, Lees AJ, et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 1989;52:1830-1836
8. Schapira AHV, Cooper JM, Dexter D, et al. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990; 54:823-827
9. Janetzky B, Hauck S, Youdim MBH, et al. Unaltered aconitase activity but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 1994;169:126-128
10. Schapira AHV. Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal. Mov Disord 1994;9:125-138
11. 1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990;55:2142-2145
12. Cooper JM, Daniel SE, Marsden CD, Schapira AHV. L-Dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain. Mov Disord 1995;10:295-297
13. Gu M, Gash MT, Cooper JM, et al. Mitochondrial respiratory chain function in multiple system atrophy. Mov Disord 1997; 12:418-422
14. Parker WD, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989;26:719-723
15. Krige D, Carroll MT, Cooper JM, et al. Platelet mitochondrial function in Parkinson's disease. Ann Neurol 1992;32:782-788
16. Haas RH, Nasirian F, Nakano K, et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol 1995;37:714-722
17. Bravi D, Anderson JJ, Dagani F, et al. Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease. Mov Disord 1992;7:228-231
18. Blake CI, Spitz E, Leehey M, et al. Platelet mitochondrial respiratory chain function in Parkinson's disease. Mov Disord 1997;12:3-8
19. Da Prada M, Cesura AM, Launay JM, Richards JG. Platelets as a model for neurones? Experientia 1988;44:115-126
20. Shoffner JM, Brown MD, Torrino A, et al. Mitochondrial DNA variants observed in Alzheimer's disease and Parkinson's disease patients. Genomics 1993;17:171-184
21. Ozawa T, Tanaka M, Ino H, et al. Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem Biophys Res Commun 1991;176:938-946
22. King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 1989;246:500-503
23. Chomyn A, Martinuzzi A, Yoneda M, et al. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA 1992;89:4221-4225
24. Dunbar DR, Moonie PA, Zeviani M, Holt IJ. Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids. Hum Mol Genet 1996;5:123-129
25. Lys mutation causing myoclonic epilepsy and ragged red fibers. Am J Hum Genet 1994; 34:966-974
26. Bodnar AG, Cooper JM, Holt IJ, et al. Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion. Am J Hum Genet 1993;53:663-669
27. Cock HR, Tabrizi SJ, Cooper JM, Schapira AHV. The influence of nuclear background on the biochemical expression of 3460 Lcbcr's hereditary optic neuropathy. Ann Neurol 1998; 44:187-193
28. Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-671
29. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-148
30. Mann VM, Cooper JM, Schapira AHV. Quantitation of a mitochondrial DNA deletion in Parkinson's disease. FEBS Lett 1992;299:218-222
31. Taanman J-W, Burton MD, Marusich MF, et al. Subunit specific monoclonal antibodies show different steady-state levels at various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia. Biochim Biophys Acta 1996;1315: 199-207
32. Reers M, Smiley ST, Mottola-Hartshorn C, et al. Mitochondrial membrane potential monitored by JC-1 dye. In: Attardi GM, Chomyn A, eds. Methods in enzymology, vol 260: mitochondrial biogenesis and genetics. San Diego: Academic Press, 1995:406-417
33. Howell N, Bindoff LA, McCullough DA, et al. Leber's hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet 1991;49: 939-950
34. Smith PR, Cooper JM, Govan GG, et al. Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sei 1994;122:80-83
35. Przedborski S, Jackson-Lewis V, Muthane U, et al. Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Ann Neurol 1993;34:715-723
36. Petty RKH, Morgan-Hughes JA. Mitochondrial myopathy: a genetic study of 71 cases. J Med Genet 1988;25:528-535
37. Zeviani M, Moraes CT, DiMauro S, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988;38: 1339-1346
38. Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet 1995;57: 77-86
39. Davis RE, Miller S, Herrnstadt C, et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci USA 1997;94:4526-4531
40. Swerdlow RH, Parks JK, Wooten GF, et al. As in Parkinson's disease, a bioenergetic defect transfers with mitochondrial DNA of patients with multisystem atrophy. Mov Disord 1997; 12(Suppl 1):3
41. Schapira AHV, Warner T, Gash MT, et al. Complex I function in familial and sporadic dystonia. Ann Neurol 1997;41:556-559
42. Tabrizi SJ, Cooper JM, Schapira AHV. Mitochondrial DNA in focal dystonia: a cybrid analysis. Ann Neurol 1998;44:258-259